CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's ImfinziZacks Investment Research • 02/04/25
Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare ConferenceBusiness Wire • 02/03/25
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJAccesswire • 02/01/25
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?The Motley Fool • 02/01/25
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?The Motley Fool • 02/01/25
Spravato sales surged highlights commercial viability of psychedelics, analysts believeProactive Investors • 01/27/25
The Stock Market Is Overbought and Insiders Are Selling – Grab These 5 High-Yield Blue Chips Now24/7 Wall Street • 01/27/25
These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024The Motley Fool • 01/25/25
JNJ ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Johnson & JohnsonAccesswire • 01/24/25
Johnson & Johnson Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - JNJAccesswire • 01/24/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Johnson & Johnson (JNJ) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 01/24/25
5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025The Motley Fool • 01/24/25
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: AnalystBenzinga • 01/23/25
Johnson & Johnson Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - JNJAccesswire • 01/23/25